MAXLINEAR, INC MXL
Nasdaq · XNAS · stock · Semiconductors & Related Devices
Chart by TradingView
5/9
Piotroski F — financial health
-1.22
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $467.6M | -$136.7M | $265.8M | $7.0M | $451.9M |
| 2024 | $360.5M | -$245.2M | $194.8M | -$63.0M | $516.3M |
| 2023 | $693.3M | -$73.1M | $385.7M | $29.9M | $686.3M |
| 2022 | $1.1B | $125.0M | $649.8M | $347.5M | $676.4M |
| 2021 | $892.4M | $42.0M | $495.8M | $129.1M | $489.2M |
| 2020 | $478.6M | -$98.6M | $212.8M | $61.1M | $391.1M |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.22 (distress)
- Working capital / assets 0.079
- Retained earnings / assets -0.628
- EBIT / assets -0.159
- Equity / liabilities 1.312
Source: SEC EDGAR filings · CIK 0001288469 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.